ARO-AAT
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Arrowhead Pharmaceuticals
Overview
ARO-AAT is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
ARO-AAT clinical trials
Explore related
Medical disclaimer. This page summarizes research about ARO-AAT for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.